Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.

Yonsei medical journal - 1 Jul 2015

Kim Yoonjung, Bae Il Kwon, Jeong Seok Hoon, Yong Dongeun, Lee Kyungwon

Abstract excerpt

PURPOSE: Colistin resistance in Acinetobacter baumannii (A. baumannii) is mediated by a complete loss of lipopolysaccharide production via mutations in lpxA, lpxC, and lpxD gene or lipid A modifications via mutations in the pmrA and pmrB genes. However, the exact mechanism of therapy-induced colistin resistance in A. baumannii is not well understood. MATERIALS AND METHODS: We investigated the genotypic and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Electrophoresis, Gel, Pulsed-Field
Share to Acinetobacter baumannii

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Acinetobacter Infections

Share to beta-Lactamases

Share to Colistin

Share to Drug Resistance, Bacterial

Share to Microbial Sensitivity Tests

Share to Molecular Typing

Source

Open in PubMed Open full text

Identifiers

PMID: 26069113
DOI: 10.3349/ymj.2015.56.4.928
PMCID: PMC4479859

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.PMID 26069113Read ↗

Colistin Resistance in Acinetobacter baumannii MDR-ZJ06 Revealed by a Multiomics Approach.Semantic proximity Read ↗

Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.Semantic proximity Read ↗

In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment.Semantic proximity Read ↗

Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.Semantic proximity Read ↗

The role of LpxA/C/D and pmrA/B g ene systems in colistin-resistant clinical strains of Acinetobacter baumanniiSemantic proximity Read ↗

Deciphering Multifactorial Resistance Phenotypes in Acinetobacter baumannii by Genomics and Targeted Label-free Proteomics.Semantic proximity Read ↗

Constitutive Phenotypic Modification of Lipid A in Clinical Acinetobacter baumannii Isolates.Semantic proximity Read ↗

Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant Acinetobacter baumanniiSemantic proximity Read ↗

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.Semantic proximity Read ↗

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumanniiSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.